Why did CDC withdraw support for FluMist influenza vaccine for kids?
Researchers are trying to see what — if any — is the common factor behind FluMist’s recent poor performance.
Researchers are trying to see what — if any — is the common factor behind FluMist’s recent poor performance.
VaxInnate, a New Jersey startup, has raised more equity - on top of $53 million in government contracts - to develop a seasonal and pandemic flu vaccine.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Wisconsin startup FluGen is developing a flu vaccine that's meant to protect against mutated forms of the virus. It just raised a $12 million Series A to do so.
Patient safety advocates affiliated with the National Patient Safety Foundation have proposed instituting a set of "must-do" practices for all healthcare organizations.
This year’s flu vaccine has proven to be an unfit match to the prominent strain. It’s unfortunate, but it has happened before. But what if there was a universal influenza vaccine that could just take care of business once and for all? Researchers at McMaster University and the Icahn School of Medicine at Mount Sinai, […]
It’s flu season, and we know there are different strains of the illness, including H3N2, influenza B, and a decendent of the swine flu, an H1 subtype. But problems are now arriving because the current vaccines don’t work with a particular strain, one that is spreading. In this case, a new H3 subtype will be tough to […]